False Narratives Get Lucrative
Newsweek US|December 29, 2023
New X ad-sharing program allows superspreaders of misinformation on viral posts to share advertising income from major brands
JACK BREWSTER, COALTER PALMER and NIKITA VASHISTH
False Narratives Get Lucrative

ON X, FORMERLY TWITTER, PRO-grammatic advertisements for dozens of major brands, governments, educational institutions and nonprofits are being displayed in the feeds directly below viral posts advancing false or egregiously misleading claims about the Israel-Hamas war, a NewsGuard analysis has found. Under the terms of a new advertising revenue sharing program that X introduced for its "creators," a portion of the advertising income generated by these organizations would apparently be shared with these superspreaders of misinformation.

From November 13 to November 22, 2023, NewsGuard analysts reviewed programmatic ads that appeared in the feeds below 30 viral tweets that contained false or egregiously misleading information about the war. Programmatic ads are served via algorithms to target digital ads to online readers. Brands typically do not select where programmatic ads run and indeed are unaware of where their programmatic ads appear.

These 30 viral tweets were posted by 10 of some of X's worst purveyors of Israel-Hamas war-related misinformation, and cumulatively reached an audience of over 92 million viewers, according to X data. On average, each tweet was seen by 3 million people. The accounts News Guard analyzed had previously been identified as repeat spreaders of misinformation about the conflict.

The 30 tweets advanced some of the most egregious false or misleading claims about the war. These include that the October 7  Hamas attack against Israel was a "false flag" and that CNN staged footage of an October 2023 rocket attack on a news crew in Israel.

この記事は Newsweek US の December 29, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Newsweek US の December 29, 2023 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

NEWSWEEK USのその他の記事すべて表示
AMERICA'S BEST LOYALTY PROGRAMS 2025
Newsweek US

AMERICA'S BEST LOYALTY PROGRAMS 2025

LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

time-read
3 分  |
February 21, 2025
Winning the Global Game
Newsweek US

Winning the Global Game

The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand

time-read
3 分  |
February 21, 2025
Solar Power
Newsweek US

Solar Power

Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality

time-read
2 分  |
February 21, 2025
Trump vs. Deep State
Newsweek US

Trump vs. Deep State

The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact

time-read
6 分  |
February 21, 2025
MAD ABOUT THE GIRL
Newsweek US

MAD ABOUT THE GIRL

AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER

time-read
10+ 分  |
February 21, 2025
Armed and Dangerous
Newsweek US

Armed and Dangerous

A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies

time-read
4 分  |
February 21, 2025
Patrick Gibson
Newsweek US

Patrick Gibson

WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.

time-read
2 分  |
February 21, 2025
The AI Will See You Now
Newsweek US

The AI Will See You Now

A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care

time-read
6 分  |
February 21, 2025
Jasmin Savoy Brown
Newsweek US

Jasmin Savoy Brown

SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.

time-read
2 分  |
February 21, 2025
BIOTECH: Blood, Sweat and Tears
Newsweek US

BIOTECH: Blood, Sweat and Tears

Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't

time-read
6 分  |
February 14, 2025